DC—CIK细胞联合厄洛替尼对EGFR基因突变阳性的晚期肺腺癌患者外周血T淋巴细胞亚群影响研究(4)
[3]Park K，Yu CJ，Kim SW，et al. First-line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in Asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer：The aspiration study[J].Jama Oncol，2015，2(3)：1-8.[4]刘爱华 ......
您现在查看是摘要页，全文长 2648 字符。